Fortis Group Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$108K Hold
18,966
0.02% 280
2026
Q1
$78.9K Hold
18,966
0.01% 288
2025
Q4
$85.2K Hold
18,966
0.01% 286
2025
Q3
$78.5K Hold
18,966
0.01% 245
2025
Q2
$32.4K Hold
18,966
0.01% 262
2025
Q1
$28.3K Hold
18,966
0.01% 238
2024
Q4
$21.2K Hold
18,966
﹤0.01% 254
2024
Q3
$18K Hold
18,966
﹤0.01% 250
2024
Q2
$30K Hold
18,966
0.01% 227
2024
Q1
$27.5K Buy
+18,966
New +$27.2K 0.01% 248

Other funds holding PGEN

Fortis Group Advisors's PGEN Position: Q2 2026 in Review

Fortis Group Advisors held its Precigen (PGEN) position steady in Q2 2026 at 18,966 shares worth $108K. The position accounts for 0.02% of the portfolio, ranked #280.

Fortis Group Advisors first reported a position in PGEN in Q1 2024 and has held it in 10 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Fortis Group Advisors held 18,966 shares of Precigen worth $108K as of Q2 2026.
  • Fortis Group Advisors left its Precigen share count unchanged in Q2 2026.
  • Precigen made up 0.02% of Fortis Group Advisors's portfolio in Q2 2026, its #280 holding.
  • Fortis Group Advisors first reported a position in Precigen in Q1 2024 and has held it in 10 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Fortis Group Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.